Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Growth (Status and Outlook) 2022-2028
- LP 4888622
- 85 Pages
- March 2022
- Pharmaceuticals
The United States Drugs for Duchenne Muscular Dystrophy (DMD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs for Duchenne Muscular Dystrophy (DMD) market, reaching US$ million by the year 2028. As for the Europe Drugs for Duchenne Muscular Dystrophy (DMD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drugs for Duchenne Muscular Dystrophy (DMD) players cover Sarepta Therapeutics, PTC Therapeutics, Pfizer, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Duchenne Muscular Dystrophy (DMD) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Eteplirsen
Deflazacort
Ataluren
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
WaVe life Science
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2017-2028
2.1.2 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Type
2.2.1 Eteplirsen
2.2.2 Deflazacort
2.2.3 Ataluren
2.3 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type
2.3.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2017-2022)
2.4 Drugs for Duchenne Muscular Dystrophy (DMD) Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.5 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application
2.5.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2017-2022)
3 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Player
3.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Players
3.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Players (2020-2022)
3.1.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Players (2020-2022)
3.2 Global Drugs for Duchenne Muscular Dystrophy (DMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs for Duchenne Muscular Dystrophy (DMD) by Regions
4.1 Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Regions (2017-2022)
4.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2017-2022)
4.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2017-2022)
4.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2017-2022)
4.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2017-2022)
5.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022)
5.3 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2017-2022)
6.2 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022)
6.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs for Duchenne Muscular Dystrophy (DMD) by Country (2017-2022)
7.2 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022)
7.3 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) by Region (2017-2022)
8.2 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022)
8.3 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Regions (2023-2028)
10.1.1 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Regions (2023-2028)
10.1.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.1.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Forecast
10.2 Americas Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Country (2023-2028)
10.2.1 United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.2 Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.3 Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.2.4 Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3 APAC Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Region (2023-2028)
10.3.1 China Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.2 Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.3 Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.4 Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.5 India Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.3.6 Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4 Europe Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Country (2023-2028)
10.4.1 Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.2 France Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.3 UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.4 Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.4.5 Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5 Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Region (2023-2028)
10.5.1 Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.2 South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.3 Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.4 Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.5.5 GCC Countries Drugs for Duchenne Muscular Dystrophy (DMD) Market Forecast
10.6 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Type (2023-2028)
10.7 Global Drugs for Duchenne Muscular Dystrophy (DMD) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.1.3 Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 PTC Therapeutics
11.2.1 PTC Therapeutics Company Information
11.2.2 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.2.3 PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 PTC Therapeutics Main Business Overview
11.2.5 PTC Therapeutics Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.3.3 Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.4.3 Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Italfarmaco
11.5.1 Italfarmaco Company Information
11.5.2 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.5.3 Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Italfarmaco Main Business Overview
11.5.5 Italfarmaco Latest Developments
11.6 Santhera Pharmaceuticals
11.6.1 Santhera Pharmaceuticals Company Information
11.6.2 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.6.3 Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Santhera Pharmaceuticals Main Business Overview
11.6.5 Santhera Pharmaceuticals Latest Developments
11.7 WaVe life Science
11.7.1 WaVe life Science Company Information
11.7.2 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
11.7.3 WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 WaVe life Science Main Business Overview
11.7.5 WaVe life Science Latest Developments
12 Research Findings and Conclusion
Table 1. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Eteplirsen
Table 3. Major Players of Deflazacort
Table 4. Major Players of Ataluren
Table 5. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2017-2022)
Table 8. Drugs for Duchenne Muscular Dystrophy (DMD) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2017-2022)
Table 11. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Player (2020-2022)
Table 13. Drugs for Duchenne Muscular Dystrophy (DMD) Key Players Head office and Products Offered
Table 14. Drugs for Duchenne Muscular Dystrophy (DMD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country (2017-2022)
Table 21. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2017-2022)
Table 23. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2017-2022)
Table 25. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2017-2022)
Table 27. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2017-2022)
Table 29. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2017-2022)
Table 31. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country (2017-2022)
Table 33. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2017-2022)
Table 35. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 44. Key Market Challenges & Risks of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 45. Key Industry Trends of Drugs for Duchenne Muscular Dystrophy (DMD)
Table 46. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sarepta Therapeutics Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 53. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 54. Sarepta Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sarepta Therapeutics Main Business
Table 56. Sarepta Therapeutics Latest Developments
Table 57. PTC Therapeutics Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 58. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 59. PTC Therapeutics Main Business
Table 60. PTC Therapeutics Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. PTC Therapeutics Latest Developments
Table 62. Pfizer Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 63. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pfizer Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Italfarmaco Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 73. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 74. Italfarmaco Main Business
Table 75. Italfarmaco Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Italfarmaco Latest Developments
Table 77. Santhera Pharmaceuticals Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 78. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 79. Santhera Pharmaceuticals Main Business
Table 80. Santhera Pharmaceuticals Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Santhera Pharmaceuticals Latest Developments
Table 82. WaVe life Science Details, Company Type, Drugs for Duchenne Muscular Dystrophy (DMD) Area Served and Its Competitors
Table 83. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Product Offered
Table 84. WaVe life Science Main Business
Table 85. WaVe life Science Drugs for Duchenne Muscular Dystrophy (DMD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. WaVe life Science Latest Developments
List of Figures
Figure 1. Drugs for Duchenne Muscular Dystrophy (DMD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2021
Figure 7. Drugs for Duchenne Muscular Dystrophy (DMD) in Hospitals
Figure 8. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Drugs for Duchenne Muscular Dystrophy (DMD) in Clinics
Figure 10. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Drugs for Duchenne Muscular Dystrophy (DMD) in Home Care
Figure 12. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market: Home Care (2017-2022) & ($ Millions)
Figure 13. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2021
Figure 14. Global Drugs for Duchenne Muscular Dystrophy (DMD) Revenue Market Share by Player in 2021
Figure 15. Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Value Market Share by Country in 2021
Figure 21. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Consumption Market Share by Type in 2021
Figure 22. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2021
Figure 23. United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region in 2021
Figure 28. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2021
Figure 29. China Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Country in 2021
Figure 36. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2021
Figure 37. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2021
Figure 38. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Market Share by Application in 2021
Figure 46. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Drugs for Duchenne Muscular Dystrophy (DMD) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 55. United States Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 59. China Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 63. India Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 66. France Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 67. UK Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Drugs for Duchenne Muscular Dystrophy (DMD) Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
